{"nct_id":"NCT06011577","title":"Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2023-08-17","start_date_type":"ACTUAL","primary_completion_date":"2024-12-19","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["RLMD"]}